These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8239697)

  • 1. [Usefulness of BFP for screening of early urinary bladder cancer].
    Ishii M; Seino Y; Tari K
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2255-7. PubMed ID: 8239697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer].
    Imamura M; Inoue K; Megumi Y; Nishimura M; Ohmori K; Nishimura K
    Hinyokika Kiyo; 2000 Oct; 46(10):705-9. PubMed ID: 11215195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic fetoprotein (BFP)].
    Ishii M; Seino Y
    Nihon Rinsho; 1999 Dec; 57 Suppl():442-4. PubMed ID: 10778159
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical study of urine NMP 22 (nuclear matrix protein 22) as a tumor marker in urinary epithelial cancer.
    Takeuchi Y; Sawada Y; Yabuki D; Masuda E; Satou D; Kuroda K; Tajima M; Sawamura Y; Matsushima M
    Aktuelle Urol; 2003 Jul; 34(4):265-6. PubMed ID: 14566681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary tumor marker for urothelial cancer].
    Ohtani M; Iwasaki A; Shiraiwa H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promising bladder cancer detection assay: the HA-HAase test.
    Ho SM; Cheng RY
    J Urol; 2004 Sep; 172(3):824-5. PubMed ID: 15310975
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
    Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; De Buitrago JM; Navajo JA
    J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Telomerase activity: a molecular marker for early diagnosis of bladder tumor].
    Calistri D; Sanchini A; Amadori D; Silvestrini R
    Recenti Prog Med; 2007 Feb; 98(2):74-8. PubMed ID: 17439065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial bladder cancer: biomarkers for detection and screening.
    Konety B; Lotan Y
    BJU Int; 2008 Nov; 102(9 Pt B):1234-41. PubMed ID: 19035887
    [No Abstract]   [Full Text] [Related]  

  • 11. Urine-based markers in bladder cancer: future prospects.
    McNeil BK; Getzenberg RH
    BJU Int; 2008 Mar; 101(6):668-9. PubMed ID: 18291016
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of urine-based biomarkers in bladder cancer.
    Grossman HB; Blute ML; Dinney CP; Jones JS; Liou LS; Reuter VE; Soloway MS
    Urology; 2006 Mar; 67(3 Suppl 1):62-4. PubMed ID: 16530080
    [No Abstract]   [Full Text] [Related]  

  • 13. Urine test boosts detection of recurrent bladder cancer.
    Hilton L
    RN; 2006 Apr; 69(4):3-4. PubMed ID: 16640017
    [No Abstract]   [Full Text] [Related]  

  • 14. Quick test for recurrent bladder cancer.
    Health News; 2006 Apr; 12(4):13. PubMed ID: 16583496
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine detection of survivin and diagnosis of bladder cancer.
    Moore M
    J Insur Med; 2001; 33(2):202-3. PubMed ID: 11510521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations].
    Fukui Y; Samma S; Fujimoto K; Akiyama T; Yamaguchi A; Hirayama A
    Hinyokika Kiyo; 2001 May; 47(5):311-4. PubMed ID: 11433750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].
    Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
    Gan To Kagaku Ryoho; 1997 May; 24(7):829-36. PubMed ID: 9170521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary markers in bladder cancer.
    Vrooman OP; Witjes JA
    Eur Urol; 2008 May; 53(5):909-16. PubMed ID: 18162285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
    Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T
    Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeleton fragments unveiling bladder cancer.
    van der Poel HG
    Eur Urol; 2007 May; 51(5):1162-3. PubMed ID: 17229517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.